ATE218060T1 - Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern - Google Patents

Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern

Info

Publication number: ATE218060T1
Authority: AT; Austria
Prior art keywords: amyloid protein; compositions; optionally substituted; protein related; prevent beta
Prior art date: 1996-07-11

Application number

AT97930746T

Other languages

English (en)

Inventor

Masaomi Miyamoto

Keisuke Hirai

Giichi Goto

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-11

Filing date

1997-07-10

Publication date

2002-06-15

1997-07-10 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2002-06-15 Application granted granted Critical

2002-06-15 Publication of ATE218060T1 publication Critical patent/ATE218060T1/de

Links

102000013455 Amyloid beta-Peptides Human genes 0.000 title abstract 2
108010090849 Amyloid beta-Peptides Proteins 0.000 title abstract 2
230000003013 cytotoxicity Effects 0.000 title abstract 2
231100000135 cytotoxicity Toxicity 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT97930746T 1996-07-11 1997-07-10 Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern ATE218060T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP18209596		1996-07-11
PCT/JP1997/002391 WO1998002149A2 (en)	1996-07-11	1997-07-10	Use of idebenone and analogues against beta amyloid induced cytotoxicity

Publications (1)

Publication Number	Publication Date
ATE218060T1 true ATE218060T1 (de)	2002-06-15

Family

ID=16112269

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97930746T ATE218060T1 (de)	1996-07-11	1997-07-10	Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern

Country Status (7)

Country	Link
US (1)	US6271266B1 (de)
EP (1)	EP0915696B1 (de)
AT (1)	ATE218060T1 (de)
AU (1)	AU3458997A (de)
CA (1)	CA2252519A1 (de)
DE (1)	DE69712888D1 (de)
WO (1)	WO1998002149A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA035619B1 (ru)	2005-06-01	2020-07-16	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Композиции для использования в способе лечения митохондриальных нарушений
JP2009508867A (ja) *	2005-09-15	2009-03-05	エジソンファーマシューティカルズ，インコーポレイテッド	ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
EP1986636B1 (de)	2006-02-22	2013-04-24	Edison Pharmaceuticals, Inc.	Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
EP1891946A1 (de) *	2006-08-14	2008-02-27	Santhera Pharmaceuticals (Schweiz) AG	Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon
PL2220030T3 (pl)	2007-11-06	2016-07-29	Bioelectron Tech Corp	Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
EP2344142B1 (de)	2008-09-10	2024-06-26	PTC Therapeutics, Inc.	Behandlung von pervasiven entwicklungsstörungen mit redox-aktiven therapeutika
US8263094B2 (en) *	2008-09-23	2012-09-11	Eastman Chemical Company	Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
HRP20161407T1 (hr) *	2010-08-16	2016-12-02	Santhera Pharmaceuticals (Schweiz) Ag	Derivati benzokinona za liječenje mitohondrijskih bolesti oka
WO2014035356A1 (en) *	2012-08-31	2014-03-06	Mahmut Bilgic	Tablet formulations comprising a quinone derivative active agent
HUE058877T2 (hu)	2014-12-16	2022-09-28	Ptc Therapeutics Inc	(R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
EP3389646A1 (de)	2015-12-17	2018-10-24	BioElectron Technology Corporation	Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen
JP7266304B2 (ja)	2017-04-21	2023-04-28	ユニヴァーシティーオブタスマニア	治療化合物および方法
HUE066196T2 (hu)	2018-10-17	2024-07-28	Ptc Therapeutics Inc	2,3,5-trimetil-6-nonilciklohexa-2,5-dién-1,4-dion alfa-szinukleinopátiák, tauopátiák és egyéb rendellenességek szuppresszálására és kezelésére
EP4366700A1 (de)	2021-07-08	2024-05-15	PTC Therapeutics, Inc.	Pharmazeutische zusammensetzungen mit 2,3,5-trimethyl-6-nonylcyclohexa-2,5-dien-1,4-dion
CN119792259A (zh) *	2024-10-14	2025-04-11	中国农业大学	艾地苯醌在制备朊病毒病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08768B2 (ja)	1989-08-24	1996-01-10	武田薬品工業株式会社	神経成長因子分泌誘導剤
JP2849286B2 (ja) *	1992-07-09	1999-01-20	三菱電機株式会社	半導体装置の製造方法
ATE184788T1 (de) *	1993-06-18	1999-10-15	Takeda Chemical Industries Ltd	Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer

1997
- 1997-07-10 DE DE69712888T patent/DE69712888D1/de not_active Expired - Lifetime
- 1997-07-10 EP EP97930746A patent/EP0915696B1/de not_active Expired - Lifetime
- 1997-07-10 US US09/180,463 patent/US6271266B1/en not_active Expired - Fee Related
- 1997-07-10 CA CA002252519A patent/CA2252519A1/en not_active Abandoned
- 1997-07-10 WO PCT/JP1997/002391 patent/WO1998002149A2/en not_active Ceased
- 1997-07-10 AT AT97930746T patent/ATE218060T1/de not_active IP Right Cessation
- 1997-07-10 AU AU34589/97A patent/AU3458997A/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0915696A2 (de)	1999-05-19
CA2252519A1 (en)	1998-01-22
AU3458997A (en)	1998-02-09
WO1998002149A3 (en)	1998-06-04
WO1998002149A2 (en)	1998-01-22
EP0915696B1 (de)	2002-05-29
DE69712888D1 (de)	2002-07-04
US6271266B1 (en)	2001-08-07

Similar Documents

Publication	Publication Date	Title
ES2134847T3 (es)	1999-10-16	Derivados de taxol.
PT1109812E (pt)	2005-09-30	Pirrolobenzodiazepinas
DE69712888D1 (de)	2002-07-04	ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
TW328535B (en)	1998-03-21	Functional photoinitiators and their manufacture
EP0513387A4 (en)	1993-04-21	Active oxygen inhibitor
AU1497997A (en)	1997-09-04	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
EA199900373A2 (ru)	1999-12-29	Фармацевтические композиции
BR9605309A (pt)	1997-10-14	Composições de derivados piperazina
ES2176402T3 (es)	2002-12-01	Compuestos sulfatos de 2,2-difluoro-3-carbomoil-ribosa y procedimientopara la preparacion de beta-nucleosidos.
FI963169A0 (fi)	1996-08-13	Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
BG103310A (en)	2000-05-31	Benzonaphthyridins as bronchial therapeutical means
PT918776E (pt)	2004-07-30	Sintese total de acilfulvenos antitumorais
ES2012646A6 (es)	1990-04-01	Un procedimiento para la preparacion de derivados de piridazinona.
AU7915491A (en)	1992-01-02	Phenyl mercaptotetrazole/tolyltriazole corrosion inhibiting compositions
EP1042352A4 (de)	2004-12-22	Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ES2122258T3 (es)	1998-12-16	4-azaesteroides 15 sustituidos.
DK1042319T3 (da)	2004-06-01	Dihydrobenzofuraner
ATE308548T1 (de)	2005-11-15	Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
NZ326675A (en)	2000-01-28	Oxazoline arthropodicides
ES2093091T3 (es)	1996-12-16	Derivado de glutation.
DE69936052D1 (de)	2007-06-21	N1 modifizierte glycopeptide
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
BG105249A (en)	2001-11-30	Fkbp inhibitors
ZA9811380B (de)	1999-06-14
ES2122751T3 (es)	1998-12-16	Composicion antialergica que comprende un compuesto diester fosforico.

Legal Events

Date	Code	Title	Description
2002-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties